96 related articles for article (PubMed ID: 8896658)
1. "Inappropriate" physician habits in prescribing oral nifedipine capsules in hospitalized patients.
Rehman F; Mansoor GA; White WB
Am J Hypertens; 1996 Oct; 9(10 Pt 1):1035-9. PubMed ID: 8896658
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
3. Oral nifedipine vs oral clonidine in the treatment of urgent hypertension.
Jaker M; Atkin S; Soto M; Schmid G; Brosch F
Arch Intern Med; 1989 Feb; 149(2):260-5. PubMed ID: 2916871
[TBL] [Abstract][Full Text] [Related]
4. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
5. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
[TBL] [Abstract][Full Text] [Related]
6. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
7. Acute antihypertensive effect of nifedipine by sublingual route in cases with clinically severe systolic hypertension. A study up to 4 h after administration.
Ito H; Arakawa M; Shibasaki T; Hirakawa S; Fukuda T; Yasue T; Kondo Y; Watanabe I; Mori N; Fueki T
Arzneimittelforschung; 1984; 34(5):630-6. PubMed ID: 6380506
[TBL] [Abstract][Full Text] [Related]
8. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the safety of short-acting nifedipine in children with hypertension.
Egger DW; Deming DD; Hamada N; Perkin RM; Sahney S
Pediatr Nephrol; 2002 Jan; 17(1):35-40. PubMed ID: 11793132
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
Al-Waili NS; Hasan NA
Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
[TBL] [Abstract][Full Text] [Related]
11. Oral slow-release nifedipine in the rapid treatment of severe hypertension in Nigerians.
Arije A; Omotoso AB; Erasmus RT
West Afr J Med; 1994; 13(2):116-20. PubMed ID: 7803325
[TBL] [Abstract][Full Text] [Related]
12. Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients.
de Macedo CR; Noblat AC; Noblat L; de Macedo JM; Lopes AA
Arq Bras Cardiol; 2001 Oct; 77(4):324-31. PubMed ID: 11733801
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
Nakayama J; Koga T; Furue M
Eur J Dermatol; 1998 Dec; 8(8):563-8. PubMed ID: 9889429
[TBL] [Abstract][Full Text] [Related]
15. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
16. Management of perioperative hypertension using sublingual nifedipine. Experience in elderly patients undergoing eye surgery.
Adler AG; Leahy JJ; Cressman MD
Arch Intern Med; 1986 Oct; 146(10):1927-30. PubMed ID: 3767537
[TBL] [Abstract][Full Text] [Related]
17. [Nitroglycerin in comparison with nifedipine in patients with hypertensive crisis].
Bussmann WD; Kenedi P; von Mengden HJ; Nast HP; Rachor M
Z Kardiol; 1993 Jan; 82(1):33-7. PubMed ID: 8470417
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
19. Rectal administration of perforated nifedipine capsules in acute severe hypertension in children.
Uchiyama M; Sakai K
Br J Clin Pract; 1992; 46(2):100-1. PubMed ID: 1457294
[TBL] [Abstract][Full Text] [Related]
20. Chewing nifedipine to rapidly treat hypertension.
Haft JI; Litterer WE
Arch Intern Med; 1984 Dec; 144(12):2357-9. PubMed ID: 6508444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
